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Abstract. The electromotility of cochlear outer hair cells
(OHCs) is a major factor in cochlear amplification that
enhances the sensitivity of hearing in humans. Prestin is
associated with presumed conformational changes in an
integral membrane protein. Prestin knockout (-/-) mice display
loss of OHC electromotility and a 40- to 60-dB reduction in
cochlear sensitivity in vivo. In the present study we described
the results of a direct sequencing mutation in the pres gene
that was found in genetic screening performed in 47 patients
characterized by non-syndromic, mild-to-moderate hearing
impairment (30-70 dB) and in 50 control subjects from
Hungary, after exclusion of GJB (GJB2, GJB6) mutations in
the background. Only one patient and his normal-hearing
father showed a heterozygous missense mutation (R150Q/
WT) in the 6th coding exon of the pres gene. None of the 50
control subjects with normal hearing carried this mutation.
Electrophysiological studies on the R150Q (homozygous and
heterozygous) prestin mutant transiently transfected into
reporting cells demonstrated nonlinear capacitance functions
(NLC) as a signature of OHC electromotility. The capacitance
function in human kidney cell line TSA 201 was similar for
wild-type prestin and the mutant. However, for the mutant
the voltage where the maximal charge displacement occurred
(V1/2) significantly shifted in the hyperpolarizing direction
(~15 mV). This is the first genetic and electrophysiological
analysis of a human mutation in a coding exon of the pres
gene by 47 patients with non-syndromic, sensorineural, mild-
to-moderate hearing impairment; although the pathogenic
role of the R150Q mutation is not unambiguous.
Introduction
Mammalian peripheral auditory processing exhibits sharp
tuning and low threshold due to a unique sensory cell type,
the outer hair cell (OHC). OHCs are not only receptor cells
which convert the mechanical energy of sound into electrical
signals (receptor potential), but they are capable of trans-
forming electrical signals into mechanical activity. This is the
so-called fast-, or electromotility (1-3). Electromotility of
OHCs is a frequency-following shortening and elongation in
the frequency range of human hearing which feeds energy
back to the cochlear partition on a cycle-by-cycle basis. This
feedback mechanism is considered to be the cochlear
amplifier. Electromotility of OHCs improves human hearing
by ~50 dB, to the sensitivity threshold level of the inner hair
cells which are the real receptor cells for hearing and which
activate the cochlear neurons. The very fast motor capability
of the OHCs is due to a modified transporter molecule, prestin,
that undergoes conformational changes upon depolarizing
and hyperpolarizing alterations of the OHC's membrane
potential (4). Concerted action of the prestin molecules in the
lateral OHC membrane manifests in cell shortening and
elongation on a μsec to msec time scale.
Prestin expression has been observed in OHCs as well as
in vestibular hair cells (VHCs), however not in the lateral
plasma membrane or in the stereociliary membrane of VHCs
(5). Analysis of its amino acid sequence indicates that it is a
hydrophobic membrane protein that belongs to the SLC26A
anion-transport family (6). Ten mammalian members of the
SLC26A family have been identified (SLC26A1-10). Prestin
is an 81-kDa protein consisting of 746 amino acids with
similarities to pendrin and other members of the solute
carrier sulphate-anion transporter family (4). It has also been
determined that both the N-terminus and the C-terminus of
prestin are located on the intracellular side, and prestin has a
highly hydrophobic core with 12 transmembrane domains
(7). Intracellular anions Cl- and HCO3- may act as voltage
sensors of prestin, or are required for prestin's function (8,9).
In contrast to the highly conserved hydrophobic core, the C-
terminus of prestin is the least conserved region of the
protein, because it has only 25-35% homology with its other
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SLC26A relatives (7). Prestin first appeared to behave as an
incomplete anion transporter (10), but recent theoretical
study suggests a transport function as well (11).
Three human genes of the SLC26A family (SLC26A2,
SLC26A3, and SLC26A4) are known to be associated with
different human recessive hereditary diseases: distrophic
dysplasia, congenital chloride diarrhea and Pendred syndrome
(12). Different mutations in SLC26A4 are responsible for
either syndromic hearing loss (Pendred syndrome) or non-
syndromic recessive hearing impairment (13). 
The human gene SLC26A5 (pres), encoding prestin,
contains 21 exons and is localized on the long arm of
chromosome 7 (7q22.1) and chromosome 5 for the human
and mouse isoforms (14). This gene is alternately spliced to
create four isoforms of prestin with variable lengths of the C-
terminus (15). Prestin knockout (-/-) mice display loss of
OHC electromotility and a 40- to 60-dB reduction in cochlear
sensitivity in vivo (16), despite apparently intact mechano-
transduction (17). Prestin knockout (-/-) mice also lose
frequency selectivity (17). Wu and colleagues reported that
prestin knockout (-/-) mice display significant hearing
impairment at high frequencies before cell death occurs.
Shorter OHCs in prestin knockout (-/-) mice suggest that
prestin also plays a structural role in the lateral wall of the
OHC. The structural instability of the OHC in prestin knock-
out (-/-) mice may be a cause of the degeneration of these
OHCs. In addition, transmission electron microscopy showed
no obvious abnormality in the stereocilia, lateral wall, tight
junctions and synapses of the prestin knockout (-/-) mouse
OHCs (18).
The role and the extent of prestin gene defects in human
non-syndromic hearing impairment (HI) are poorly understood.
A single nucleotide change in the 2nd intron of SLC26A5 has
been reported to be associated with hearing loss (15). This
IVS2-2A>G DNA sequence variation occurs in the first coding
exon 3 splice acceptor site of the pres gene. It has been
suggested that this mutation leads to aberrant mRNA splicing
and results in non-syndromic moderate-to-profound sensori-
neural HI predominantly at high frequencies in patients with
the heterozygous IVS2-2A>G mutation, and severe-to-
profound HI by homozygous probands. However, further
study demonstrated that the SLC26A5 IVS2-2A>G variant
may not occur more frequently in hearing impaired patients
than in controls, and heterozygosity for this transition may not
be sufficient to cause hearing loss (19). Cheatham and
colleagues demonstrated that measurements of nonlinear
capacitance in isolated OHCs, as well as the voltage
dependence and sensitivity of motor function, did not differ
in the heterozygote knockout and wild-type mice, and neither
did auditory threshold and frequency selectivity. These
results suggest that one copy of the pres gene is able to
compensate for the deleted copy and that heterozygous mice
do not suffer hearing impairment (20).
The purpose of this study was to examine whether hearing
was impaired as a result of a certain mutation in the SLC26A5
gene in humans. We describe the results of a direct sequencing
mutation analysis in the pres gene that was performed in 47
patients characterized with mild and moderate hearing
impairment (30-60 dB) and in 50 control subjects from
Hungary. All individuals were tested for the most common
genetic defects for hearing impairment in Hungary as well,
the connexin 26 and connexin 30 mutations (21). When a
genetic defect was detected, the pathogenic role of the given
mutation was examined through a functional study. 
Materials and methods
All 47 subjects participating in the study were from Hungary.
The age of the patients varied between 3 and 30 years (mean,
15.6 years). No consanguinity was found among the patients.
The hearing impairment was mild-to-moderate (30-70 dB),
non-syndromic, sensorineural and bilateral in all cases.
Information on the patients' medical history was obtained in
personal interviews with the affected individuals or with their
unaffected relatives. Patients who had any obvious risk
factors (syphilis, rubeola, toxoplasma, CMV, HIV, meningitis,
ototoxic drug use, head and acoustic trauma, premature birth,
fetal alcohol syndrome, thyroid disease, kidney disease,
neurodegenerative disorders, or other congenital and
chromosomal abnormalities) were not included in this study.
Informed consent was obtained from each individual and
from the parents of children. This study was approved by the
Ethics Committee of the University of Debrecen. 
Audiologic methods. All persons involved in the study
underwent otoscopic and audiometric examinations by using
age-appropriate methods. The pure-tone threshold audio-
metric configuration was classified according to the guidelines
of the European Work Group on Genetics of Hearing
Impairment (22). Asymmetry of the hearing threshold (>10-dB
hearing level difference between the ears at least at two
frequencies) was not observed for any subject. Distortion
oto-acoustic emission (sound pressure level is plotted against
frequency) showed no response on either side in all the
patients tested. Auditory brainstem response (ABR) measure-
ments were performed in selected cases. Auditory steady-
state response (ASSR - to modulated 0.5-kHz and 4-kHz
tones) was measured in only one genetically affected case.
Genetic analysis. Genetic analysis of GJB2 (connexin 26,
NM_004004.3), GJB6 (connexin 30, AL590096.16) and pres
(ENSG00000170615) genes was based on gene structure
information provided by their GenBank accession nos. and/or
Ensemble gene ID's.
Genomic DNA was extracted from ‘buffy coat’ by using
QIAamp DNA blood mini kit (Qiagen) according to the
manufacturer's instructions. For PCR amplification and DNA
sequencing of the GJB2 and pres genes, custom primer pairs
were designed using Primer Premier 5 (Premier Biosoft
International). The primer pairs amplified the coding exons
and the surrounding intronal and/or UTR regions of the
respective genes (Table I). PCR conditions were as follows:
100 ng genomic DNA was amplified in a 50-μl volume
containing 5 μl of Buffer I, 0.4 μl of 25 mM dNTPs, 2 units of
AmpliTaq Gold® DNA polymerase (Applied Biosystems),
20 pmole of each specific primer and 5% DMSO. PCR
reactions were run on a GeneAmp 9600 (Applied Biosystems)
PCR instrument according to the following conditions: after
an initial denaturation/polymerase activation at 96˚C for
10 min, 35 cycles were performed (1-min denaturation at
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96˚C, 1-min annealing at an exon-specific temperature and
1-min elongation at 72˚C) followed by a 10-min incubation
at 72˚C. The annealing temperature was 57˚C for GJB2, 54˚C
for Prestin exons 2-21 and 62˚C for pres exon 1. The
PCR products were checked by 3% agarose gel electro-
phoresis and purified using High Pure 96 UF Cleanup kit
(Roche). The sequencing primers in the case of pres were the
same as those used for the PCR reactions. For GJB2, besides
the PCR primers, additional sequencing primers were also
used.
Sequencing was carried out in 20-μl reaction volumes in
a 96-well GeneAmp 9600 PCR machine using the BigDye
Terminator v3.1 Cycle Sequencing kit (Applied Biosystems)
containing 3.2 pmole sequencing primer, 8 μl PCR template,
4 μl dye terminators, and 4 μl 5X sequencing buffer. Reactions
were cycled by running at 96˚C for one min, followed by 25
cycles of 96˚C for 30 sec, 50˚C for 15 sec and 60˚C for 4 min.
Unincorporated dye terminators and residual salts were
removed by using the DyeEx 96 kit (Qiagen). Samples were
run on 3100 Avant DNA analyzer (Applied Biosystems). The
sequencing results were aligned against reference sequences
using Seqscape software v.2 (Applied Biosystems).
GJB6 analysis. The del(GJB6-D13S1830) mutation of the
GJB6 (connexin 30) was evaluated by allele-specific PCR
method. Using primers for1 (gccatgcatgtggcctacta), rev1
(actatctgaaatcagctcattc) and for2,del (cattgttgtgaactaacctcca,
GenBank no. AL590096.16) a 441-bp PCR product was
generated for wild-type alleles and a 480-bp fragment was
produced for an allele representing the deletion.
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Table I. The primer pairs used to amplify the coding exons of the pres gene and the surrounding intronal and/or UTR regions
of the GJB2 and GJB6 genes.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Forward primer (5'-3') Reverse primer (5'-3')
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Prestin
Exon 1 TATATTTGCGGGGATCGAC TTAGGGAAAAAGCGCGAC
Exon 2 AGCCACTGTGATAGCAGTAGC ACTACCTCTGACCCACTCTCC
Exon 3 TCAGAAGAACTTGGAACACC CAGCATTCATTTTTCTCTCC
Exon 4 TCCACCCACCTTGAAAAT CAATTGTTTGAGGACAGCA
Exon 5 AGATGATGTGCAGGACTGG TGACCATGCTATTTCTTTGG
Exon 6 CCATATCAGATACTCTGAACC CCACCGTGTAGTAAGACC
Exon 7 CCCGTGTCTACTAAAAATACA GGGAATAAAGAGAAAAGTACC
Exon 8 GGCTGGTGTGAATTAGTGC TTTTGGCAGAATTGAGAGC
Exon 9 GAACATTCATCTCTAAAGGTGC ATTAGCCAGGTGTGGTAGC
Exon 10 CAACCAGAGCAAATAAGTATCC TTCACCATGTTAGCCAGG
Exon 11 ATGAAGAGATAGGCTGTAGTGC CCCTACACAGCTCACTGG
Exon 12 AACCAACTTATGCCCTGC TTGGCCCTTTCTCATACC
Exon 13 GCTTCAAAGCTACCATCG ACACACACATGCTACTTTTACC
Exon 14 AGATCTCCCCTTTTTCTGG AGTCAACATTGTCATCTCTGC
Exon 15 CAAATGCACCAGCAAACC GCTCAGACTTTTCACTTTGACC
Exon 16 GCAGCAGCCTTCCATCTCC CAACCCACAAATCCCATCCTC
Exon 17 GATAATCTGACCCAGAAAGC ATAACTGACCTTATCAGGTGC
Exon 18 GAACACAAGAGCAGATTTTCC TTGTTGAAAAGAGAGCCTAGC
Exon 19 GTCTTCTATCACGAAAAACA ATATTAAGCTTCACCCCA
Exon 20 CTGATATCCAGAGTGTGG GTACAATACATCTTGCTAGG
Exon 21 GACCTCACTCGGAATAGATT TCGATGCTTAGCTTACAAAG
GJB2
Exon 2 GCATTCGTCTTTTCCAGAGC CCTACAGGGGTTTCAAATGG
Seq1 GAAGAGGAAGTTCATCAAG
Seq2 ATTCACTCTTTATCTCCCC
Seq3 ACCAGCATTGGAAAGATCTG
Seq4 ATGACCCGGAAGAAGATGCTG
GJB6
Exon 2 GCATATTTGCTTCCTTCCAGC CCTATACCCGGCTAGACAGC
Seq1 AGTCAGAACTCAGAACACTGC
Seq2 GACAACGCAGGCAAGAAGC
Seq3 ATCGTACTCACCATCTGTGAGC
Seq4 AGAGGAACTCAATGATGAGC
Seq5 TCAGGTTGGGTGCTGAAGC
Seq6 TCAGAGTGGGGTCACTCAGC
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
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Pres DNA constructs and generation of mutant forms of
prestin. Gerbil Prestin (gPrestin) was cloned into the vector
pcDNA3.1 (4). A QuickChange® Site-Directed Mutagenesis
kit (Stratagene, La Jolla, CA, USA) was used to generate
wild-type (wt) prestin and the R150Q mutant. The nucleotide
exchanges were confirmed by DNA sequencing as described
previously (23). The heterozygote form was mimicked by
mechanical mixing in the ratio of 1:1 of the wt and R150Q
form. This procedure was used previously by Matsuda et al
(24).
Cell culture and transfection. TSA201 cells were transiently
transfected with the wild-type and the R150Q mutant prestin
form. Both had a GFP tag on the N-terminal for the visual-
ization of the transfected cells. The transfection reagent was
Effectene (Qiagen, Valencia, CA) (7). cDNA (0.4 μg) was
used for one 35-mm culture dish. The TSA cell culturing was
as previously described (23). To perform whole cell
recordings, the cells were dissociated 48 h after transfection
with non-enzymatic Cell Dissociation solution (Sigma
C5914) and transferred to a Poly-D-lysine-covered dish
(Becton Dickinson). 
Patch-clamp recording . The recording glass pipette
(Borosilicate glass, Fisher, TW 150-4) tip resistance was
between 1.5 and 2.4 MΩ. The solution inside the pipette
contained 130 nM CsCl, 2 nM MgCl2, 10 nM EGTA, and
10 nM HEPES at pH 7.2. The bath solution (ionic blocking
solution) had the following composition: 99 nM NaCl, 20 nM
TEA-Cl, 2 nM CoCl2, 1.47 nM MgCl2, 1 nM CaCl2, 10 nM
HEPES and 4.6 g glucose at pH 7.2. Glucose was used to
adjust the osmolarity to 300±4 mosmol l-1. The cell selection
and recording procedure was similar to that described
previously (23).
Data collection. The recorded capacitance functions were
stored and fitted to the first derivative of a two-state
Boltzmann function (25). 
QmaxCv = Clin + ––––––––––––––––––––––V - V1/2
-
V - V1/2
α e α (1 + e α )2
The maximal charge transfer (Qmax) depends on cell size,
consequently the Qmax was divided by linear capacitance
(Clin) and named charge density (fC/pF) (26). The software
Igor Pro (WaveMetrics, Lake Oswego, OR) was used for
data analysis and curve fitting. 
Statistics. To analyze the differences between electrical
properties of mutant and wild-type pres, we transfected two
dishes simultaneously (one with wild-type and another with
the mutant). The cells were from the same passage. We first
measured at least 12 cells from the wild-type group and
afterward also ~12 cells from the mutant. Thereby two
populations were compared. The statistical significance
levels were estimated by unpaired two-tailed Student's t-
tests. All data were presented as average and standard
deviation. A probability value of p<0.05 was considered
significant.
Results
Genetic analysis. All 47 subjects selected for this study
suffered from a sporadic, sensorineural, bilateral, mild-to-
moderate hearing disorder based on pure tone audiometry (at
frequencies 0.5, 1, 2, and 4 kHz), with unknown etiology and
with normal middle ear function. None of the patients had a
mutation in the coding region of GJB2. The 309-kb deletion
[Δ(GJB6-D13S1830)] GJB6 was not detectable in any samples
as well. Each coding exon of the human pres was analysed in
all cases. One p.R150Q heterozygous missense mutation was
detected in exon 6 in one of the 47 patients (Pr-H1). This
mutation represents a GA transversion in codon 150,
resulting in an amino acid change from arginine (basic) to
glycine (polar) (Fig. 1). The degree of hearing impairment in
this child with the p.R150Q heterozygous genotype was
estimated at 60-70 dB at all frequencies by auditory steady
state response (ASSR) measurement. Further pres sequencing
analysis was performed on his parents to verify the inheritance
of the R150Q mutation. It was shown that the 34-year-old
father (Pr-H2) also had the mentioned DNA change in
heterozygous form. Pure-tone threshold audiograms, oto-
acoustic emission, as well as ABR measurements showed
normal patterns in both parents. The p.R150Q mutation
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Figure 1. DNA sequencing of coding exon 6 of the pres gene. R150Q heterozygous missense mutation showing GA transversion in codon 150 by patient Pr-H1.
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screening in the pres gene was performed on 50 Hungarian
control subjects with reported normal hearing. None of them
carried this mutation. 
Nonlinear capacitance (NLC) of the R150Q mutant. Several
transfected TSA cells were measured and the recorded values
within the same genotype (wt or mutant) were averaged. The
daily control was required because, depending on the trans-
fection efficiency, the charge density can change from batch
to batch. The three main electrical properties (charge density,
V1/2 and α) of the voltage-dependent capacitance function
were compared between the wild-type and the mutant. 
The average charge density of the R150Q mutant was
9±6 fC/pF (n=16). The corresponding control wild-type
control displayed 7±4 fC/pF (n=12). The difference between
the two population means was not significant (p>0.05). The
recorded charge density for the hetero form (R150Q/WT) was
14±8 fC/ pF (n=13) and compared to its own daily control,
10±8 fC/pF (n=14). The level of significance was p>0.05. 
The peak voltage of the capacitance function (V1/2) of the
R150Q homozygote mutant was -112±12 mV. The daily
control of the wt prestin was -63± 7 mV. This 49-mV hyper-
polarization shift was significant (p<0.01). The heterozygote
R150Q/WT mutant displayed -89±17 mV while the daily
control was -58±8 mV. The difference (29 mV) was still
significant (p<0.001). Thus, both homozygous and hetero-
zygous forms of the R150Q mutation showed significant
differences in their V1/2 compared to the wild-type.
The α values, the slope factor of the NLC curves, were
similar in each case; for the homozygote mutant it was
32±2 mV (control value, 29±5 mV) and for the heterozygote
mutant it was 29±5 mV (control value, 28±4 mV) (Fig. 2).
There was no statistically significant difference between the
mutant and its own control (p>0.05).
Discussion
This is the first genetic and electrophysiological analysis of a
human mutation in a coding exon of the pres gene in patients
with non-syndromic, sensorineural, mild-to-moderate hearing
impairment.
Examination of hearing impaired patients (n=47), after
exclusion of GJB mutations in the background, resulted in the
discovery of a heterozygous mutation in the pres gene. This
mutation was also found in the father of the subject who was
without hearing loss. No similar mutation was seen in the
age- and gender-matched control group of normal hearing
listeners (n=50). Out of the tested individuals with a hearing
impairment of >40 dB and a sloping audiometric chart towards
the high frequencies associated with the absence of evoked
oto-acoustic emission (TOAE) and GJB mutations (connexin
26 and connexin 30) only 1 patient (Pr-H1) showed a
heterozygous missense mutation in the pres gene. The
mutation was a R150Q/WT in the 6th coding exon. Although
this young male carrier did not produce oto-acoustic
emissions, his father (Pr-H2) with the same mutations did.
This finding makes it unlikely that the mutant prestin was the
causative factor in the hearing impairment.
Electrophysiological studies on an R150Q mutant prestin
transfected kidney cell line exhibited a hyperpolarization
shift in the voltage-dependent nonlinear peak capacitance of
~30 mV. Since in a heterozygote subject, the normal gene
copy can still produce wild-type prestin in the outer hair
cells, it is unlikely that the mutation described here was
responsible for the hearing loss. We can only speculate on
the putative influence of such a mutation in the outer hair cell
function in e.g. a homozygous genotype. 
First, the exchange of Arg to Gly decreases the
effectiveness of phosphorylation upon the prestin molecule.
Consequently, mutant prestin is less modifiable by metabolic
influences and hence its contribution in dynamic stiffness
regulation of the OHC lateral wall decreases (27). 
Second, Arg is a positively charged amino acid, which
may closely be involved in the charge carrier function of
prestin. As this is a basic mechanism in the cochlear amplifier
role of the OHCs in mammalian hearing this mutation can
change the charge carrier characteristics of the prestin
molecules.
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Figure 2. Normalized nonlinear capacitance functions of the R150Q mutant and wild-type prestin in transfected TSA cells. Each curve represents the
individual cell that approximately describes the mean of the population. Thin lines with different markings represent the actual data, and thick lines show
curve fitting according to equation 1. In the case of the R150Q mutant form, the voltage where the maximal prestin movement occurred (V1/2), shifted to the
hyperpolarizational direction (p<0.005) compared to wild-type prestin. For clearer presentation each NLC curve was normalized to 1 because their charge
density did not show significant differences.
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Third, an ~30-mV hyperpolarizing shift in the voltage-
dependent nonlinear peak capacitance in homozygotes can
affect the transfer curve of electromotility (a voltage to
movement conversion in the OHCs) with a consequence of
energy-feedback change or feedback phase change resulting
in hearing impairment. 
In other words, mutant homozygous prestin performs
smaller elongation displacements and greater contractions
than the wild-type. Also, the electromotility magnitude of
contraction + elongation decreases.
To summarize, it is at least possible that one copy of this
mutation also produces a highly variable phenotype, maybe
even normal hearing in some cases. Certainly in the animal
model, the (+/-) genotype corresponds to normal function
(for knockout mouse). Maybe in the case of modified prestin,
the contributions of R150 and Q150 vary from case to case
and so does prestin function and hearing loss. 
Acknowledgements
This study was supported by the Hungarian National
Research Fund (OTKA-K63743), by ETT 206/2006 and by
the Medical and Health Science Center, University of
Debrecen, Mecenatura grant (16/2005). The authors are
grateful to all subjects for their participation in this study. We
further thank Prof. Peter Dallos (Northwestern University,
Evanston) for helpful discussions on the research project and
manuscript, as well as Judit Szilvássy (our Department) and
Laszlo Noszek (Department of ENT, University of Budapest)
for their audiological work.
References
1. Brownell WE, Bader CR, Bertrand D and de Ribaupierre Y:
Evoked mechanical responses of isolated cochlear outer hair
cells. Science 227: 194-196, 1985.
2. Kachar B, Brownell WE, Altschuler R and Fex J: Electrokinetic
shape changes of cochlear outer hair cells. Nature 322: 365-368,
1986.
3. Ashmore JF: A fast motile response in guinea-pig outer hair
cells: the cellular basis of the cochlear amplifier. J Physiol 388:
323-347, 1987.
4. Zheng J, Long KB, Shen W, Madison LD and Dallos P: Prestin
is the motor protein of cochlear outer hair cells. Nature 405:
149-155, 2000.
5. Adler HJ, Belyantseva IA, Merritt RC Jr, Frolenkov GI,
Dougherty GW and Kachar B: Expression of prestin, a
membrane motor protein, in the mammalian auditory and
vestibular periphery. Hear Res 184: 27-40, 2003.
6. Mount DB and Romero MF: The SLC26 gene family of
multifunctional anion exchangers. Pflugers Arch 447: 710-721,
2004.
7. Zheng J, Long KB, Shen W, Madison LD and Dallos P: Prestin
topology: localization of protein epitopes in relation to the
plasma membrane. NeuroReport 12: 1929-1935, 2001.
8. Oliver D, He DZZ, Klöcker N, et al: Intracellular anions as the
voltage sensor of prestin, the outer hair cell motor protein.
Science 292: 2340-2343, 2001.
9. Rybalchenko V and Santos-Sacchi J: Cl- flux through a non-
selective, stretch-sensitive conductance influences the outer hair
cell motor of the guinea-pig. J Physiol 547: 873-891, 2003.
10. Dallos P and Fakler B: Prestin, a new type of motor protein. Nat
Rev Mol Cell Biol 3: 104-111, 2002. 
11. Muallem D and Ashmore J: An anion antiporter model of
prestin, the outer hair cell motor protein. Biophys J 90: 4035-4045,
2006.
12. Everett LA and Green EDA: Family of mammalian anion
transporters and their involvement in human genetic diseases.
Hum Mol Genet 8: 1883-1891, 1999.
13. Li XC, Everett LA, Lalwani AK, et al: A mutation in PDS
causes non-syndromic recessive deafness. Nat Genet 18:
215-217, 1998.
14. Zheng J, Long KB, Matsuda KB, Madison LD, Ryan AD and
Dallos PD: Genomic characterization and expression of mouse
prestin, the motor protein of outer hair cells. Mamm Genome
14: 87-96, 2003.
15. Liu XZ, Ouyang XM, Xia XJ, et al: Prestin, a cochlear motor
protein, is defective in non-syndromic hearing loss. Hum Mol
Genet 12: 1155-1162, 2003.
16. Liberman MC, Gao J, He DZZ, Wu X, Jia S and Zuo J: Prestin
is required for electromotility of the outer hair cell and for the
cochlear amplifier. Nature 419: 300-304, 2002.
17. Cheatham MA, Huynh KH, Gao J, Zuo J and Dallos P:
Cochlear function in Prestin knockout mice. J Physiol 560:
821-830, 2004.
18. Wu X, Gao J, Guo Y and Zuo J: Hearing threshold elevation
precedes hair cell loss in prestin knockout mice. Brain Res Mol
Brain Res 126: 30-37, 2004.
19. Tang HY, Xia A, Oghalai JS, Pereira FA and Alfrod RL: High
frequency of the IVS2-2A>G DNA sequencing variation in
SLC26A5, encoding the cochlear motor protein prestin,
precludes its involvement in hereditary hearing loss. BMC Med
Genet 6: 30, 2005.
20. Cheatham MA, Zheng J, Huynh KH, et al: Cochlear function in
mice with only one copy of the prestin gene. J Physiol 569:
229-241, 2005.
21. Toth T, Kupka S, Haack B, et al: GJB2 mutations in patients
with non-syndromic hearing loss from Northeastern Hungary.
Hum Mutat 6: 631-632, 2004.
22. European Work Group on Genetics of Hearing Impairment. Info
Letter, Nov. 2, 1996.
23. Deák L, Zheng J, Orem A, et al: Effects of cyclic nucleotides on
the function of prestin. J Physiol 563: 483-496, 2005.
24. Matsuda K, Zheng J, Du GG, Klocker N, Madison LD and
Dallos P: N-linked glycosylation sites of the motor protein
prestin: effects on membrane targeting and electrophysiological
function. J Neurochem 89: 928-938, 2004.
25. Santos-Sacchi J: Reversible inhibition of voltage-dependent
outer hair cell motility and capacitance. J Neurosci 10: 3096-3110,
1991.
26. Oliver D and Fakler B: Expression density and functional
characteristics of the outer hair cell motor protein are regulated
during postnatal development in rat. J Physiol 519: 791-800,
1999.
27. He DZ, Jia S and Dallos P: Prestin and the dynamic stiffness of
cochlear outer hair cells. J Neurosci 8: 9089-9096, 2003.
TOTH et al:  MUTATION IN HUMAN pres GENE550
545-550  10/9/07  12:10  Page 550
